Cardiovascular and Cerebrovascular Drugs
Category:
Time: 2021-11-20
【SUMMARY】
| Drug Name | Specifications | Rank | Type |
|---|---|---|---|
| Rosuvastatin Calcium Tablets | 5mg | New Category 4 with Increased Specifications | |
| Felodipine Extended-Release Tablets | 5mg | New Category 4 | |
| Rosuvastatin Calcium Tablets | 10mg | New Category 4 | |
| Valsartan and Amlodipine Tablets (I) | Valsartan 80 mg, amlodipine 5 mg | New Category 4 | |
| Pentoxifylline Sustained-Release Tablets | 400mg | The first exclusive | New Category 3 |
| Pentoxifylline Injection | 5 ml: 0.1 g | New Category 3 | |
| Urapidil Hydrochloride Injection | 5 ml: 25 mg | The 3rd store | New Category 4 |
| Terbutaline Sulfate Injection | 1 ml: 0.5 mg | The 3rd store | New Category 3 |
| Urapidil Hydrochloride Injection | 10 ml: 50 mg | The 3rd store | New Category 4 |
| Pitavastatin Calcium Tablets | 1mg | The 3rd store | New Category 4 |
| Pitavastatin Calcium Tablets | 2mg | The 3rd store | New Category 4 |
| Metoprolol Tartrate Injection | 5 ml: 5 mg | The 3rd store | Consistency |
Cardiovascular and Cerebrovascular Medications
Keywords:
More Announcements
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091